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MACROPHAGES harvested from the peritoneal cav-
ities of rats release a neutrophil chemotactic
factor (MNCF) in response to stimulation with
Gram-negative bacterial lipopolysaccharide (LPS).
MNCF has been shown to be active in rats treated
with dexamethasone, a glucocorticoid that usually
inhibits the neutrophil migration induced in this
species by interleukin (IL)-1, tumour necrosis
factor alpha (TNFa), IL-8, C5a and leukotriene B4
(LTB4). Here we report that macrophages har-
vested from peritoneal cavities of mice, and
stimulated in vitro with LPS, also release a factor
that induces neutrophil migration in dexametha-
sone-treated animals. This chemotactic activity
was neutralized by the incubation of the LPS-
stimulated macrophage supernatants with a pur-
i￿ ed polyclonal IgG anti-mouse TNFa. In addition,
signi￿ cant amounts of TNF were detected in the
supernatants. The neutrophil migration induced
by intraperitoneal administration of recombinant
murine TNFa was also unaffected by pretreatment
of the mice with dexamethasone. Moreover,
neutrophil migration induced by intraperitoneal
injection of LPS was completely blocked by pre-
treatment of the mice with a monoclonal anti-
body against murine TNFa. In conclusion, our
results support the hypothesis that, in contrast to
the role of TNF in rats (where it indirectly induces
neutrophil migration), in mice, it may be an
important mediator in the recruitment of neutro-
phils to in￿ ammatory sites.
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Introduction
Neutrophil migration is a key event in acute
in￿ammatory reactions. This is a complex and
multimediated event and remains not comple-
tely understood. Chemotactic mediators are
generally derived either from plasma compo-
nents or from multiple cellular sources,1,2 and
one of the most important cellular sources of
neutrophil chemotactic factors is resident
macrophages.1,3 In fact, it has been shown that
neutrophil migration into the peritoneal cavity,
induced by carrageenin, endotoxin, latex beads
or zymozan, is increased when the number of
resident macrophages is augmented by pretreat-
ment with thioglycollate, and reduced after
depletion of the peritoneal macrophage popula-
tion through previous washing of the cavity.4
The chemotactic mediators thought to be
involved in neutrophil migration into in￿amed
tissues include the ￿fth complement compo-
nent fragment, C5a,5 leukotriene B4 (LTB4),6
and the pleitropic cytokines interleukin (IL)-1,7
tumour necrosis factor alpha (TNFa),7 and IL-8.8
Some of these substances, such as C5a, may
have a direct chemotactic effect on neutro-
phils;5 others may act indirectly through me-
chanisms which depend upon the resident cells
of the tissues, and the endothelium.7,8 IL-1, TNF
and LTB4, for example, not only increase the
expression of adhesion molecules but also
stimulate the release of chemotactic factors by
rat resident macrophages.7 Furthermore, neutro-
phil migration into the peritoneal cavities of rats
induced by these substances is also dependent
on the number of resident macrophages.7 An-
other potent leukocyte chemoattractant cyto-
kine is IL-8, which has been shown to induce
neutrophil migration by means of a mast cell
dependent mechanism, since its activity cannot
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of mast cells or in mice lacking this cellular
population.8 Furthermore, rat mast cells stimu-
lated with IL-8 release a neutrophil chemotactic
activity into the supernatant.8
It has been demonstrated that macrophages
incubated in vitro with either LPS3 or IL-1 and
TNFa7 release a neutrophil chemotactic factor
named MNCF (macrophage-derived neutrophil
chemotactic factor) into the supernatant. This
factor has a mol.wt of 54 kDa, a PI, 4 0 and
lectin-like activity.9 The neutrophil migration
induced by MNCF in rats is unaffected by the
variation of the number of resident peritoneal
cells, as well as by pretreatment of animals with
glucocorticoids. Based upon these results, it
was suggested that MNCF may be a mediator
involved in the recruitment of neutrophil in-
duced by various in￿ammatory stimuli, such as
the cytokines IL-1 and TNFa in rats.
The fact that the glucocorticoids did not
affect MNCF-induced neutrophil migration con-
￿icts with the hypothesis that glucocorticoids
block the expression of adhesion molecules in
the neutrophil and endothelium.10 It thus seems
reasonable to speculate that certain stimuli,
such as MNCF , can by-pass one or more critical
steps which are sensitive to glucocorticoids,
inducing leukocyte migration, whereas other
stimuli, even though capable of by-passing some
of these steps, cannot cause in vivo neutrophil
migration in glucocorticoid-treated animals.
Thus, it has been shown that in the hamster
chick-pouch model of in￿ammation, dexametha-
sone failed to block the LTB4-induced neutro-
phil adherence to and migration through
endothelial cells.11 In this model the neutrophils
were halted in the lamina basal, between the
endothelial cells and the pericyte, never reach-
ing the intersticial space.
The present study shows that LPS-stimulated
mouse macrophage monolayers release an
MNCF-like mediator into culture supernatants
since these supernatants induced neutrophil
migration into the peritoneal cavities of animals
pretreated with dexamethasone. Not only were
signi￿cant amounts of TNFa deteted in the
supernatants, but their in vivo neutrophil
chemotactic activity was also neutralized by
preincubation with a puri￿ed polyclonal IgG
anti-mouse TNFa. Furthermore, the neutrophil
recruitment induced by the intraperitoneal ad-
ministration of recombinant murine TNFa was
not affected by the treatment of the mice with
dexamethasone. A monoclonal antibody against
TNF was also shown to be able to block the
LPS-induced neutrophil migration to the peri-
toneal cavities of mice completely.
Materials and Methods
Reagents
LPS isolated from Escherichia coli O111B4
was purchased from Sigma (St Louis, MO).
Recombinant murine TNFa (rmTNFa) was do-
nated by Dr M. A. Palladino (Genentech Inc.,
South San Francisco, CA). The rat monoclonal
antibody against rmTNFa (XT22.11) was pur-
i￿ed from mice ascitic peritoneal ￿uids by
af￿nity chromatography on Sepharose-protein G
(Sigma).
Animals
Male 8- to 10-week-old C57BL/6 mice (Centro
Multinstitucional de Bioterismo-CEMIB/UNI-
CAMP , Campinas, SP , Brazil) were housed in a
temperature-controlled room and received
water and food ad libitum throughout the
period of study.
Preparation of anti-TNF sera
Polyclonal rabbit antisera against recombinant
murine TNFa were produced in New Zealand
rabbits, as described elsewhere.12 Brie￿y, on day
0, 100 mg of rmTNFa were diluted in 500 ml of a
phosphate buffered saline solution (PBS) and
mixed with an equal volume of Freund’s com-
plete adjuvant, and the emulsion was injected
intradermically into the rabbits. Boosting with
intradermal injections of emulsions containing
50, 10, and 10 mg of rmTNF , in 50% Freund’s
incomplete adjuvant, occurred on days 15, 30
and 45, respectively. The rabbits were bled 10
days after the ￿nal injection. Speci￿c antibodies
against TNF present in the sera were detected
by immunoblotting and capacity to block the
effect of TNF on WEHI cells. In some experi-
ments, antibodies obtained by chromatography
of the sera in DEAE-Sepharose, according to the
manufacturer’s recommendations, were used as
an IgGfraction.
LPS stimulated murine macrophage
supernatants
Mouse peritoneal cavities were stimulated by
the injection of a 3% thioglycollate solution
(DIFCOLaboratories; Detroit, MI) (3 ml/animal).
Four days later, the peritoneal cells were
harvested with RPMI 1640 (Flow Laboratories,
McLean, VA) and seeded on plastic tissue
culture dishes at a density of 2 3 106 cells/5ml/
plate. The cells were allowed to adhere for 1 h
at 378 C, in an atmosphere of air with 5%CO2.
Adherent cells (95%macrophages) were washed
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for 30 min with 5 mg/ml of LPS in RPMI or
with RPMI alone. The supernatants were dis-
carded and the cells were extensively washed
with PBS, followed by a ￿nal 2 h incubation at
378 C with 5 ml of RPMI medium per dish
(without LPS or fetal calf serum). The cell-free
incubation ￿uids were subsequently ultradia-
￿ltered through a YM10 membrane with a cut-
off 10 Kd (Amicon Corp., Lexington, MA, USA).
The ￿nal volumes (corresponding to 5%of the
original volume) were ￿ltered on 0.22 mm mem-
branes (Millipore; Bedford, MA) and the samples
were kept at 708 C for TNF detection and
neutrophil migration assays.
Detection of TNF in the supernatants
The TNF content in macrophage supernatants
was measured using a highly TNF-sensitive cell
line, WEHI 164 clone 13, as described else-
where.13 Brie￿y, WEHI cells were seeded on
microplates (Costar 3596, Cambridge, MA) at a
density of 4 3 104 cells/well in 50 ml of growth
medium (RPMI 1640 medium containing 10%
fetal calf serum (Gibco)). Fifty ml of diluted
supernatants were added to the cells, and
the experiments were conducted in triplicate.
The plates were incubated for 20 h at 378 C in a
5% CO2 incubator; 10 ml of a 3-4,5-dimethyl-
thiazol-2-l-3,5-diphenylformazan solution (5 mg/
ml PBS) (MTT , Sigma) were added to each
well and the plates incubated for an additional
4 h. One hundred ml of isopropanol containing
0.04 N HCl were added to each well. Fifteen
min later, the degree of cell lysis was deter-
mined spectrophotometrically (570 nm) using
an enzyme-linked immunoassay analyser
(Multiskan MCC/340 MKII, Flow Laboratories).
TNF content in the assayed materials was
calculated by comparison with standard curves
which were determined with rmTNF (Genen-
tech Inc.). The results correspond to the
averages obtained in at least three independent
experiments.
The presence of the TNF in the supernatants
was con￿rmed by ELISA assays using the mono-
clonal antibody against TNF (XT 22.11) as the
coating antibody (10 mg/ml) and the rabbit
polyclonal antibodies (serum dilution 1:200)
as the detecting antibody. The bound rabbit
antibodies were revealed using an immuno-
peroxidase conjugate anti-rabbit IgG, and the
chromogenic substrat OPD (Sigma). In our
system, it was possible to detect amounts of
TNF varying between 50 to 0.25 ng/ml,
according to standard curves performed with
mrTNFa.
In vivo neutrophil migration
The method for testing in vivo neutrophil
migration has been described elsewhere.3
Brie￿y, LPS solutions (8± 1000 ng/0.2 ml of sal-
ine solution/animal), rmTNFa (10± 100 mg/
0.2 ml/animal) and either LPS-stimulated or non-
stimulated macrophage supernatants (equiva-
lent to the products released by 2 3 106 adher-
ent cells/0.2 ml/animal) were injected into the
peritoneal cavities of mice pretreated subcuta-
neously (s.c.) with dexamethasone (0.5 mg/kg)
1 h previously. Controls received intraperitoneal
(i.p.) injections of sterile saline solution. Six
hours after these i.p. injections, the mice were
sacri￿ced in a CO2 chamber, and their perito-
neal cavities washed with 3 ml of PBS contain-
ing 5 IU/ml of heparin; total and differential cell
counts in the washing ￿uid were conducted as
described elsewhere.14 The results are ex-
pressed as means standard error of the mean
(SEM) for the number of neutrophils per ml of
peritoneal wash.
In some experiments, rmTNFa was incubated
for 30 min at 378 Cwith polyclonal IgGanti-TNF
(100 mg IgG/100 ng TNF) prior to the i.p. injec-
tions. The control groups for these experiments
received i.p. injections of the same quantity of
the antibody diluted in saline solution.
In other experiments, monoclonal antibody
against TNF (XT22.11) was administrated intra-
peritoneally to mice (100 mg/cavity) 1 h before
the i.p. injections of saline solution (0.2 ml/
cavity) or LPS (200 ng/cavity), with control
group receiving i.p. injections of saline solution
prior to the in￿ammatory stimulus.
Protein measurement
The protein contents of puri￿ed materials was
determined according to the method of
Hartree.15
Statistical analysis
The data are presented as the means SEM,
with statistical comparisons between the groups
performed using the Student t-test for unpaired
samples.
Results
Time course and dose dependence of
LPS-induced neutrophil migration in
mice
The intraperitoneal injection of increasing doses
of LPS in naive mice induced a dose-dependent
neutrophil migration with a bell-shaped curve
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with a dose of 200 ng LPS/cavity, peaking be-
tween 8 and 12 h after the LPS administration,
and returning to control levels after 48 h (Fig.
1B); the neutrophil migration induced by the
dose of 1000 ng/cavity was less than that ob-
served with the other doses tested.
Effects of dexamethasone
pretreatment of mice and pre-
incubation of the LPS-stimulated
macrophage supernatants with TNF
speci® c antibodies on capacity to
induce neutrophil migration
The supernatants from LPS-stimulated macro-
phages induced a signi￿cant neutrophil migra-
tion into the peritoneal cavities of naive mice,
which was not signi￿cantly inhibited by the
pretreatment of the animals with dexametha-
sone (Fig. 2A). The dexamethasone treatment,
however, reduced the neutrophil migration
induced by saline solution. On the other hand,
the pre-incubation of these supernatants (from
2 3 106 adherent cells) with the IgG fraction of
anti-rmTNFa serum (100 mg) eliminated their
capacity to induce neutrophil migration into
peritoneal cavities of dexamethasone-pretreated
mice (Fig. 2B). The same quantity of IgG did
not interfere with neutrophil migration in the
control group.
TNF concentration in the LPS-
stimulated macrophage supernatants
The TNF concentration for ￿ve different sam-
ples of LPS-stimulated macrophage super-
natants, derived from the culture of 2 3 105
adherent cells, varied from 1 to 14 ng as
detected by activity and/or ELISAassays.
Effect of dexamethasone
pretreatment on neutrophil migration
induced by recombinant murine
TNFa in mice
The intraperitoneal administration of rmTNFa
in naive mice induced a dose-dependent neutro-
phil migration which peaked 5± 10 h after the
injection. In dexamethasone-pretreated mice,
rmTNFa also induced a dose-dependent neutro-
phil migration, which was determined 6 h later;
the migration induced by a dose of 0.1 mg TNF/
cavity in naive mice was similar to that ob-
served for dexamethasone-pretreated animals
(Fig. 3A). Fig. 3B shows that the neutrophil
chemotactic activity of the rmTNFa was com-
pletely eliminated by pre-incubation with an
anti-TNFa IgG.
Effect of treatment with
dexamethasone or TNF speci® c
antibody on LPS-induced neutrophil
migration in mice
The intraperitoneal injection of LPS in naive
mice induced signi￿cant neutrophil migration
which was suppressed by pretreatment with
dexamethasone (Fig. 4A). This LPS-induced
neutrophil migration was completely eliminated
by pretreatment of the animals with a mono-
clonal antibody against TNFa (Fig. 4B).
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FIG. 2. Effects of dexamethasone pretreatment and preincu-
bation of LPS-stimulated mouse macrophage supernatants
with speci® c antibody to rmTNFa on capacity to induce
neutrophil migration. (A) Bars represent neutrophil migra-
tion induced by saline solution or LPS-stimulated mouse
macrophage supernatants (LPS-Mw SUP) into peritoneal
cavities of mice, pretreated ( , hatched bars) or not ( ,
open bars) with dexamethasone (Dexa). (B) Bars represent
neutrophil migration induced by LPS-Mw SUP, incubated
( ) or not ( ) with 100 mg of IgG anti-rmTNFa, into
peritoneal cavities of dexamethasone-pretreated mice. Con-
trol groups received i.p. injections of saline solution or
saline solution containing IgG anti-TNFa (100mg/0.2 ml/ani-
mal). In both panels, the results are reported as mean
SEM for six animals in the group. P , 0 05 (Student’s t-
test).
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FIG. 1. Dose response and time course of neutrophil migra-
tion induced by LPS. (A) Bars represent neutrophil migra-
tion induced by the indicated doses of LPS into peritoneal
cavities of mice. The control (C) represents neutrophil
migration induced by saline solution. The neutrophil migra-
tion was analysed 6 h after the injection of the stimuli. The
number of animals per experimental group is indicated at
the top of the bars. (B) Time course of neutrophil migration
induced by either LPS (200 ng/cavity) or saline solution
(control group). The number of animals per group was ® ve.
In both panels, the results are reported as mean SEM.
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The intraperitoneal injection of LPS in mice
caused a signi￿cant, dose and time-dependent,
neutrophil migration with a bell-shaped dose-
response curve, as was found in other
species.16,17 This may be due to the liposolu-
bility of the LPS and the fact that when it is
injected in high concentrations into extravascu-
lar tissue, the amount that enters the circulatory
system is suf￿cient to block neutrophil migra-
tion. It has, for example, been demonstrated
that intravenous administration of LPS inhibits
the neutrophil migration induced by various
stimuli, including LPS itself.16 It has recently
been demonstrated that macrophages harvested
from the peritoneal cavities of rats and stimu-
lated in vitro with LPS release MNCF , a neutro-
phil chemotactic factor.18 Rat macrophages
stimulated in vitro with IL-1 and TNF also
release MNCF .7 The neutrophil migration in-
duced by such MNCF is unaffected by the
number of resident cells or by the treatment of
the rats with dexamethasone.19 The fact that
this glucocorticoid did not affect the neutrophil
migration induced by MNCF made the factor
distinguishable from the other known neutro-
phil chemotactic mediators, since it has been
demonstrated that the neutrophil migration
induced by IL-1, TNF , IL-8, FMLP , C5a and LTB4
in rats is inhibited by treatment with
dexamethasone.7,8 It is thus suggested that in
rats MNCF may be a late mediator in the
recruitment of neutrophil induced by various
stimuli, including the cytokines IL-1 and TNF .
In the present study we demonstrated that
macrophages harvested from peritoneal cavities
of mice and stimulated with LPS for a brief
period of time also released a neutrophil che-
motactic factor into the supernatants, and the
activity of this factor was not signi￿cantly
inhibited by pre-treatment of animals with
dexamethasone, at least at doses that block the
neutrophil migration induced by LPS.
The incubation of the supernatant with an
antibody against murine TNF blocked the
neutrophil chemotactic activity, thus suggesting
that the presence of the TNF was responsible
for this activity. This fact also suggested that the
neutrophil chemotactic activity of the super-
natant was due to the presence of the TNF . The
presence of TNF in the supernatant was then
con￿rmed, and dose-dependent neutrophil mi-
gration in dexamethasone-treated mice was
induced by the intraperitoneal administration of
recombinant murine TNF . This neutrophil mi-
gration was not statistically different from that
observed in untreated mice. The antibody that
blocked the neutrophil chemotactic activity of
the LPS-stimulated macrophage supernatant also
eliminated it for rmTNF . The fact that the
quantity of mrTNF necessary to induce neutro-
phil migration was greater than that found in
the supernatant might be explained by the lack
of glycosylation in the recombinant form, since
it is well established that the level of glycosyla-
tion affects the speci￿c activity of this cytokine.
These results are in contrast to those obtained
in rats, where the neutrophil migration induced
by TNF is blocked by pre-treatment with
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FIG. 3. Effect of dexamethasone pretreatment on the
neutrophil migration induced by rmTNFa in mice. (A) Bars
represent neutrophil migration induced i.p. injection of
saline solution (SAL) or of the indicated amounts (in mg/
animal) of rmTNFa into peritoneal cavities of dexametha-
sone-pretreated or naive mice (hatched and open bars,
respectively). (B) Bars represent neutrophil migration in-
duced by 0.1mg rmTNFa, preincubated ( ) or not ( ) with
100 mg of IgG anti-TNFa, into peritoneal cavities of dexa-
methasone-pretreated mice. The control animals (SAL)
received i.p. injections of saline solution containing IgG
anti-TNFa (100mg/0.2 ml/animal). In both panels, the results
are reported as means SEM for six animals in the group.
P , 0 05 (Student’s t-test).
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FIG. 4. Effects of pretreatment of mice with either dexa-
methasone or monoclonal antibody against murine TNFa
on neutrophil migration induced by LPS. (A) Bars represent
neutrophil migration induced by i.p. injection of saline
solution (0.2 ml/cavity) or of LPS (200 ng/cavity) in dexa-
methasone-pretreated or non-treated mice ( , hatched and
, open bars, respectively). (B) Bars represent neutrophil
migration induced by saline solution (0.2 ml/animal) or by
LPS (200 ng/animal) into peritoneal cavities of mice either
pretreated ( , hatched bars) or not ( , open bars) with
monoclonal antibody against TNFa (100mg/animal). In both
panels, the results are reported as means SEM for ® ve
animals in the group. P , 0 05 (Student’s t-test).
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induces neutrophil migration via MNCF .7
In mice, the TNF generation upon LPS injec-
tion was suppressed by in vivo administration
of a monoclonal antibody against TNF
(XT22.11), which blocked the neutrophil migra-
tion induced by the endotoxin. It has recently
been demonstrated that TNF is also involved in
neutrophil migration into the lung induced by
intratracheal challenge of presensitized mice
with Schistosoma mansoni egg antigen.20
It is well documented that glucocorticoids
inhibit the release of several cytokines, includ-
ing TNF .21 30 This fact could explain the inhibi-
tory effect of dexamethasone on the neutrophil
migration induced by LPS. The blockage of
neutrophil-endothelium adhesion has been sug-
gested as a mechanism by which the glucocorti-
coids inhibit the migration, although in vitro
experimental evidences does not support this
interpretation.31 The in vivo monitoring of
different stages of neutrophil migration showed
that dexamethasone did not inhibit rolling or
adhesion to the venular endothelium induced
by LTB4 and fMLP in hamsters.32 Moreover,
glucocorticoid treatment did not inhibit neutro-
phil penetration through the endothelial cell
junctions. It was thus concluded that, in addi-
tion to the effect of corticoids on the release of
chemotactic mediators, they blocked the ￿nal
step of migration because the neutrophils re-
mained between the endothelium and the basal
membrane without reaching the perivascular
tissue.32 Haptotaxis seems to be an important
mechanism in this ￿nal step, and the binding of
the chemoattractant to a sub-endothelial or
tissue matrix seems to be an important require-
ment for the process. In support of this hypoth-
esis, in vitro evidence is provided to show that
MNCF and IL-8 are able to induce migration
through a haptotatic gradient, although they
recognize different ligands.33 Since dexametha-
sone blocks the neutrophil migration induced
by IL-8 but does not affect the MNCF activity, it
is postulated that glucocorticoids may be able
to block the expression of the IL-8 ligand while
not affecting that of MNCF .33 Thus, TNF prob-
ably induces neutrophil migration in mice
through a mechanism similar to that described
for MNCF in rats, although the expression of
the extravascular ligand to TNF in mice is not
affected by glucocorticoid treatment. It is im-
portant to point out that, despite the fact that
MNCFis not released in signi￿cant quantities by
mouse macrophages, as demonstrated in the
present study, when MNCF from rat macro-
phages was injected in dexamethasone pre-
treated mice, the neutrophil migration observed
was similar to that observed in normal mice
(data not shown).
In conclusion, the results reported here sup-
port the hypothesis that, in contrast to rats, in
which TNF induces neutrophil migration
through an indirect mechanism, in mice TNF
may be a late mediator involved in the recruit-
ment of neutrophil into an in￿ammatory site.
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